Pharvaris N.V. (PHVS)Healthcare | Biotechnology | Zug, Switzerland | NasdaqGS
28.58 USD
-0.20
(-0.695%) ⇩
(April 17, 2026, 4 p.m.
EDT)
After hours: 28.58 Short-term: ★★★☆☆ | Long-term: ★★☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 11, 2026, 3:14 p.m. EDT
PHVS is a high-risk, high-reward biotechnology stock with significant volatility and negative fundamentals. The recent price action shows some consolidation, but the stock has been in a downtrend. The options market indicates a cautious outlook with a focus on downside protection, suggesting that traders are wary of further declines. While there are positive analyst ratings, the stock's lack of dividends and weak earnings make it unsuitable for dividend-focused investors. Long-term investors should consider the potential for growth in the biotech sector, but the current fundamentals and market sentiment suggest a cautious approach. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.029367 |
| AutoETS | 0.029445 |
| AutoARIMA | 0.029445 |
| MSTL | 0.033913 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 55% |
| H-stat | 2.65 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.802 |
| Excess Kurtosis | -0.38 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 0.286 |
| Market Cap | 1,869,355,648 |
| Forward P/E | -9.08 |
| Beta | -2.58 |
| Previous Name | Pharvaris B.V. |
| Website | https://pharvaris.com |
As of April 11, 2026, 3:14 p.m. EDT: Options speculators are showing mixed signals. For near-term expirations, there is a notable concentration of puts around the 25.0 strike, indicating some bearish sentiment. However, for longer-dated options, there's a slight bullish tilt with calls at higher strikes, suggesting some optimism about potential price increases. The overall options activity seems to reflect cautious positioning with a focus on downside protection.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.98482764 |
| Address1 | Grafenauweg 8 |
| All Time High | 42.86 |
| All Time Low | 1.77 |
| Ask | 28.91 |
| Ask Size | 1 |
| Average Analyst Rating | 1.4 - Strong Buy |
| Average Daily Volume10 Day | 189,220 |
| Average Daily Volume3 Month | 159,624 |
| Average Volume | 159,624 |
| Average Volume10Days | 189,220 |
| Beta | -2.581 |
| Bid | 28.44 |
| Bid Size | 1 |
| Book Value | 4.894656 |
| City | Zug |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | Switzerland |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 28.58 |
| Current Ratio | 10.106 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 29.89 |
| Day Low | 28.49 |
| Debt To Equity | 0.286 |
| Display Name | Pharvaris |
| Earnings Timestamp | 1,775,133,000 |
| Earnings Timestamp End | 1,778,589,000 |
| Earnings Timestamp Start | 1,778,589,000 |
| Ebitda | -169,633,776 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -9.382 |
| Enterprise Value | 1,591,534,976 |
| Eps Current Year | -2.93891 |
| Eps Forward | -3.147468 |
| Eps Trailing Twelve Months | -3.5 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 27.1367 |
| Fifty Day Average Change | 1.4433002 |
| Fifty Day Average Change Percent | 0.053186286 |
| Fifty Two Week Change Percent | 98.482765 |
| Fifty Two Week High | 29.89 |
| Fifty Two Week High Change | -1.3099995 |
| Fifty Two Week High Change Percent | -0.04382735 |
| Fifty Two Week Low | 13.81 |
| Fifty Two Week Low Change | 14.7699995 |
| Fifty Two Week Low Change Percent | 1.0695148 |
| Fifty Two Week Range | 13.81 - 29.89 |
| Financial Currency | EUR |
| First Trade Date Milliseconds | 1,612,535,400,000 |
| Float Shares | 35,085,410 |
| Forward Eps | -3.147468 |
| Forward P E | -9.080315 |
| Free Cashflow | -79,089,728 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 129 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.051659998 |
| Held Percent Institutions | 0.90670997 |
| Implied Shares Outstanding | 65,407,822 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,021-02-05 |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases. The company develops deucrictibant, a small molecule bradykinin B2-receptor antagonist to treat attacks due to bradykinin-mediated angioedema, including hereditary angioedema (HAE) and acquired angioedema due to C1-inhibitor deficiency (AAE-C1INH), which is in phase 3, as well as in phase 3 trials for treatment and prophylaxis of HAE attacks; and extended-release tablet and immediate-release capsule formulation of deucrictibant. Pharvaris N.V. was incorporated in 2015 and is headquartered in Zug, Switzerland. |
| Long Name | Pharvaris N.V. |
| Market | us_market |
| Market Cap | 1,869,355,648 |
| Market State | POST |
| Max Age | 86,400 |
| Message Board Id | finmb_402951024 |
| Most Recent Quarter | 1,767,139,200 |
| Name Change Date | 2,026-04-16 |
| Net Income To Common | -175,699,392 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 1,890,286,055 |
| Number Of Analyst Opinions | 13 |
| Open | 29.25 |
| Operating Cashflow | -137,073,632 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 31 712036410 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 28.58 |
| Post Market Time | 1,776,456,605 |
| Prev Name | Pharvaris B.V. |
| Previous Close | 28.78 |
| Price Eps Current Year | -9.724694 |
| Price Hint | 2 |
| Price To Book | 5.8390207 |
| Profit Margins | 0.0 |
| Quick Ratio | 10.006 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.38462 |
| Region | US |
| Regular Market Change | -0.20000076 |
| Regular Market Change Percent | -0.69492966 |
| Regular Market Day High | 29.89 |
| Regular Market Day Low | 28.49 |
| Regular Market Day Range | 28.49 - 29.89 |
| Regular Market Open | 29.25 |
| Regular Market Previous Close | 28.78 |
| Regular Market Price | 28.58 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 148,412 |
| Return On Assets | -0.35808 |
| Return On Equity | -0.65190005 |
| Sand P52 Week Change | 0.36506534 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 65,407,822 |
| Shares Percent Shares Out | 0.0109 |
| Shares Short | 712,119 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 751,905 |
| Short Name | Pharvaris N.V. |
| Short Percent Of Float | 0.0134000005 |
| Short Ratio | 4.08 |
| Source Interval | 15 |
| Symbol | PHVS |
| Target High Price | 76.447395 |
| Target Low Price | 30.264767 |
| Target Mean Price | 46.77399 |
| Target Median Price | 42.82537 |
| Total Cash | 291,678,880 |
| Total Cash Per Share | 4.459 |
| Total Debt | 776,798 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -3.5 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 24.500525 |
| Two Hundred Day Average Change | 4.0794754 |
| Two Hundred Day Average Change Percent | 0.16650563 |
| Type Disp | Equity |
| Volume | 148,412 |
| Website | https://pharvaris.com |
| Zip | 6,300 |